$CTKB News

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026

Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement

Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets

Cytek Biosciences, Inc. (CTKB) Presents at Singular Research's Las Vegas Invitational Conference - Slideshow

Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference

Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026

Stephens & Co. Maintains Overweight on Cytek Biosciences, Lowers Price Target to $4.75

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $5.5

Cytek Biosciences, Inc. 2026 Q1 - Results - Earnings Call Presentation

Cytek (CTKB) Q1 2026 Earnings Call Transcript

Cytek Biosciences, Inc. Q1 2026 Earnings Call Summary

Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript

Cytek Biosciences Q1 Earnings Call Highlights

Cytek Biosciences Reports First Quarter 2026 Financial Results

Cytek Biosciences Affirms FY2026 Sales Guidance of $205.000M-$212.000M vs $208.235M Est

Cytek Biosciences Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $44.135M Miss $44.328M Estimate

Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates

Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact